☆ 4.7 Editorial Material

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?

CARDIOVASCULAR DIABETOLOGY (2020)

Journal

CARDIOVASCULAR DIABETOLOGY

Volume 19, Issue 1, Pages -

Publisher

BMC

DOI: 10.1186/s12933-020-01119-z

Keywords

SGLT2i; Hyperglycemia; Xylazine; Infarct size; Ischemia-reperfusion

Categories

Cardiac & Cardiovascular Systems Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.